Clinical Trials Logo

Clinical Trial Summary

Catheter ablation in patients with ventricular tachycardia using a new mapping algorithm called, parallel mapping, that is aimed to increase the specificity of mapping and the outcome of ablation.


Clinical Trial Description

In patients with scar in the hearts after heart attacks, the risk for dangerous abnormal heart rhythms, including sudden death is high. This is because dead muscle fibers are replaced by scar tissue, creating a physiological condition promoting abnormal heart rhythms.These abnormal heart rhythms are called ventricular arrhythmias or ventricular tachycardias. In these patients, ablation procedures can be helpful, however the recurrence rate of arrhythmias after ablation remains unacceptably high. The primary reason for this high recurrence rate is nonspecific mapping methodologies for identifying the heart area responsible for these arrhythmias. Therefore, new methods for increasing the specificity of mapping have been the subject of significant research for many years, however implementation of these methods in clinical practice has been challenged by limited technologies. Recently, a new mapping technology named "parallel mapping" has been developed, received FDA approval and is routinely utilized at the Cleveland Clinic. However, the workflow of using parallel mapping, and the efficacy of ablation using this technology have not been evaluated. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04477499
Study type Observational
Source The Cleveland Clinic
Contact
Status Completed
Phase
Start date July 15, 2020
Completion date December 30, 2022

See also
  Status Clinical Trial Phase
Completed NCT00376532 - Extracellular Matrix Marker of Arrhythmia Risk (EMMA) N/A
Recruiting NCT04848844 - The PAtients pResenTing With COngenital HeaRt DIseAse Register (ARTORIA-R)
Completed NCT06039397 - The Effect of Semi Fowler 30' Right Lateral on Cardiac Output in Acute Heart Failure N/A
Completed NCT04025762 - 24/7 Closed-loop in Older Subjects With Type 1 Diabetes N/A
Not yet recruiting NCT03619018 - All Inclusive KODEX - EPD™ Study Patient Specific Optimized Therapy (PSOT) Study
Completed NCT03786640 - Abbott Brady 3T MRI PMCF
Recruiting NCT05935007 - Aveir DR Real-World Evidence Post-Approval Study
Recruiting NCT05932602 - AVEIR DR Coverage With Evidence Development (CED) Study
Recruiting NCT01988064 - Face to Face vs. Group Training Methods on Pulse Rate Taking in Patients With Cardiovascular Diseases. N/A
Recruiting NCT06310707 - Arrhythmia Identification in Syncope Patients: ePatch® Versus 24h Holter N/A
Terminated NCT03481413 - Patient Specific Optimized Therapy Post-Market Clinical Follow-up Study
Recruiting NCT05443321 - Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes N/A
Recruiting NCT03801681 - ARrhythmias in MYocarditis
Completed NCT03628534 - SERF VT Ablation Early Feasibility Study (EFS) N/A
Recruiting NCT05034432 - The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients Phase 4
Recruiting NCT04856267 - Exploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders
Not yet recruiting NCT06414447 - Electrocardiogram (ECG) Validation Study
Completed NCT02401659 - Importance of Patient´s Satisfaction With Telemedicine Based on Monitoring Systems N/A
Recruiting NCT05790642 - Comparison of Different Non-invasive Methods to Assess Pulse Wave Analysis
Recruiting NCT04833712 - Stereotactic Radioablation for the Treatment of Refractory Atrial Fibrillation N/A